Hemorrhoid Drugs Market size is likely to expand at significant growth rate during the forecast period i.e., between 2024-2036.
The market’s growth is influenced by the increasing cases of hemorrhoids backed by various factors such as increasing prevalence of lifestyle-based diseases, lack of physical exercise, obesity, increasing alcohol consumption, low fiber intake in diet, and growing demand for treatment options. According to the World Health Organization statistics, over 38 million children, below the age of 5 were suffering from obesity in 2019. In fact, the number of obese people globally, has tripled since 1975. Increasing number of obese people is, in turn, expected to increase the prevalence of hemorrhoid, which is projected to positively influence the market growth. Moreover, rising prominence of lifestyle diseases, such as diabetes, and hypertension, is anticipated to elevate the number of people suffering from piles. According to another data by the WHO, over 422 million people around the globe suffer from diabetes, and it causes about 1.6 million deaths every year. On account of these factors, the demand for hemorrhoid drugs is anticipated to increase over the forecast period.
Growth Drivers
Challenges
Base Year |
2023 |
Forecast Year |
2024-2036 |
Regional Scope |
|
The global hemorrhoid drugs market is segmented by end-user into hospitals, home care, specialty clinics, and others, out of which, the hospitals segment is anticipated to hold the largest share over the forecast period owing to the complications associated with the disease. The homecare segment is also estimated to witness significant growth by the end of 2036, owing to the increasing acceptance of homecare for the older patients. On the basis of disease type, the external hemorrhoids segment is anticipated to garner major market share over the forecast period, owing to the use of drugs as a treatment approach for external hemorrhoids, whereas, surgery is preferred for internal hemorrhoids.
Our in-depth analysis of the global market includes the following segments
By Drug Type |
|
By Disease Type |
|
By Distribution Channel
|
|
By End User
|
|
Regionally, the global hemorrhoid drugs market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region.
Europe Market Statistics
Europe industry is expected to dominate majority revenue share by 2036, on the back of high geriatric population, coupled with availability of advanced treatment options, better reimbursement policies and fast commercialization of novel products. The EU includes 27 countries, including France, Belgium, Germany, and Luxemburg among others. Moreover, presence of well-established healthcare infrastructure and high disposable income in the region are anticipated to propel the growth of the hemorrhoid drugs market in the region.
APAC Market Analysis
The hemorrhoid drugs market in the Asia Pacific is estimated to witness the highest CAGR during the forecast period, owing to the increasing population, growing healthcare sector, and emerging pharmaceutical companies.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?